Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?

• Published in: Annals of medicine (Helsinki) Vol. 54; no. 1; pp. 617 - 621
• Main Authors: Greco, N., Meacci, A., Mora, B., Vestri, A., Picarelli, A.
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis 31.12.2022; Taylor & Francis Group
• Subjects: autoimmune disease; Celiac Disease - diagnosis; Celiac Disease - epidemiology; Celiac Disease - genetics; coeliac disease; COVID-19; COVID-19 - complications; COVID-19 - genetics; Critical Care; Gastroenterology & Hepatology; Haplotypes; HLA-DQ Antigens - genetics; Human leukocyte antigen (HLA); Humans; Pandemics; SARS-CoV-2; COVID-19; coeliac disease; SARS-CoV-2; Human leukocyte antigen (HLA); autoimmune disease

The coronavirus disease 2019 (COVID-19), an acute respiratory disease caused by a novel coronavirus (SARS-CoV-2), is emerging as a worldwide public health emergency. Several scientific contributions reported the potential relevance of human leukocyte antigen (HLA) polymorphism and susceptibility to...